More articles from Airway pharmacology and treatment

CAPTAIN: Improvements in airflow obstruction in patients with uncontrolled asthma
Dave Singh, Zelie Bailes, Neil Barnes, Louis-Philippe Boulet, Roland Buhl, Rekha Chaudhuri, Frances Gardiner, Ian Pavord, Emilio Pizzichini, David Slade, Claus F. Vogelmeier, John Oppenheimer

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3383; DOI: 10.1183/13993003.congress-2021.PA3383
Shared decision making in severe asthma therapy: qualitative study of physician-patient communication
Ember Lu, Katya Solovyeva, Zachary Hebert, Lisa Kietzer, Simon Griffiths, Zeina Eid Antoun, Tom Keeley, Rafael Alfonso-Cristancho

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3535; DOI: 10.1183/13993003.congress-2021.PA3535
CAPTAIN: Effects of triple therapy on FEV1 response in patients with inadequately controlled asthma on ICS/LABA
Huib A.M. Kerstjens, Carl Abbott, Louis-Philippe Boulet, Sarah Chang, Geoffrey Chupp, Jodie Crawford, Nicola A. Hanania, Robert Nathan, John Oppenheimer, Emilio Pizzichini, Hironori Sagara, William Busse

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3386; DOI: 10.1183/13993003.congress-2021.PA3386
A preliminary study to identify correlations between blood glucose levels and cardiorespiratory observations in acute asthma patients receiving nebulised salbutamol
Craig Mortimer

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3527; DOI: 10.1183/13993003.congress-2021.PA3527
Real life data on the use of inhaler device, the satisfaction and the adherence of treatment evaluated by the pharmacists
Bilun Gemicioglu, Nejdiye Mazican, Gunay Can, Ilkay F. Alp Yildirim, Sonmez B. Uydes Dogan

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3398; DOI: 10.1183/13993003.congress-2021.PA3398
Late Breaking Abstract - Response to mepolizumab in patients with severe CRSwNP using EUFOREA 2021 criteria
Claire Hopkins, Joseph K Han, Valerie J Lund, Claus Bachert, Zuzana Diamant, Wystke Fokkens, Ana R Sousa, Steven G Smith, Shibing Yang, Bhabita Mayer, Steve W Yancey, Robert Chan, Stella E Lee

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3536; DOI: 10.1183/13993003.congress-2021.PA3536
CAPTAIN: Relationship between FEV1 reversibility at screening as a continuous variable and treatment response
Guy Brusselle, Neil Barnes, Roland Buhl, Frances Gardiner, Liam G. Heaney, Hiromasa Inoue, Giselle Mosnaim, Alberto Papi, Emilio Pizzichini, Jun Tamaoki, Claus F. Vogelmeier, Agne Zarankaite, Ian Pavord

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3384; DOI: 10.1183/13993003.congress-2021.PA3384
SABA use increase weeks before asthma exacerbations recorded via a digital inhaler
Mark Levy, Guilherme Safioti, Michael Reich, Randall Brown, Michael Depietro

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3397; DOI: 10.1183/13993003.congress-2021.PA3397
Drug Delivery Performance and Fugitive Emission Comparison of Two Commercially Available Nebulizer Systems
Mark Nagel, Nathaniel Hoffman, Jason Suggett

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3402; DOI: 10.1183/13993003.congress-2021.PA3402
Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme
Darush Attar, Toby Capstick, Deborah Leese, Sofie Arnetorp, Eleni Rapsomaniki, Keith Peres Da Costa, Yang Xu, Jennifer K Quint

European Respiratory Journal Sep 2021, 58 (suppl 65) PA3525; DOI: 10.1183/13993003.congress-2021.PA3525

Main menu

User menu

Search

More articles from Airway pharmacology and treatment

Pages

Contact us